00:00
00:00
00:00
ValiRx - Article accepted for publication of VAL401

ValiRx, the clinical stage biotechnology company, is pleased to announce the acceptance for publication of the first article containing results from the VAL401 clinical trial by the European Journal of Drug Metabolism and Pharmacokinetics.

Suzanne Dilly
CEO, ValiSeek Limited

Company Events - VALIRX PLC